[Massive lower gastrointestinal bleeding due to diverticular disease during antiplatelet therapy. Case report].
Diverticular disease is very frequent in Western countries; in 5% of the cases it is the cause of serious bleeding, haemodynamic instability and death. The authors report a case of 74 years old patient with severe lower gastrointestinal bleeding. She was in antiplatelet treatment with acetylsalicylic acid (100 mg/die) and clopidogrel (75 mg/die) for preventing the restenosis of medicated stents positioned to treat an acute coronary syndrome. At the same time the patient was under treatment for primary hypercholesterolemia with rosuvastatin (20 mg/die). The severe haemorrhage demanded haemodynamic stabilization, achieved by colloid infusion and blood transfusions. The bleeding continued; selective arteriography showed it's origin from the areas of the sigmoid and superior hemorrhoidal arteries. During the procedure, embolization of the inferior mesenteric artery using spiral type BALT was performed, with consequent bleeding interruption. Fifteen days after the embolization, a rectosigmoid colonoscopy showed a sigmoid diverticular disease. The treatment with acetylsalicylic acid and clopidogrel has surely contributed to the severity of the hemorrhage. Recent experimental and clinical evidence suggests a possible antiplatelet effect of the statins.
Spaziani
E
E
Università degli Studi di Roma La Sapienza, I Facoltà di Medicina e Chirurgia, Polo Pontino Ospedale A. Fiorini di Terracina.
Stagnitti
F
F
Iozzino
M
M
Notarianni
E
E
Cianni
R
R
Toccaceli
S
S
Casciaro
E G
EG
Gammardella
P
P
Di Filippo
A
A
Policicchio
V
V
Martellucci
A
A
Stagnitti
A
A
Budak
A
A
Di Pucchio
E
E
Calì
B
B
De Angelis
F
F
Corelli
S
S
D054058:Acute Coronary Syndrome / Q000628:therapy; D000368:Aged; D001241:Aspirin / Q000008:administration & dosage / Q000009:adverse effects; D000077144:Clopidogrel; D023903:Coronary Restenosis / Q000517:prevention & control; D004240:Diverticulum / Q000150:complications* / Q000175:diagnosis*; D054855:Drug-Eluting Stents; D005260:Female; D005464:Fluorobenzenes / Q000008:administration & dosage / Q000009:adverse effects; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced / Q000209:etiology*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D006937:Hypercholesterolemia / Q000188:drug therapy; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects*; D011743:Pyrimidines / Q000008:administration & dosage / Q000009:adverse effects; D000068718:Rosuvastatin Calcium; D012810:Sigmoid Diseases / Q000150:complications* / Q000175:diagnosis*; D013449:Sulfonamides / Q000008:administration & dosage / Q000009:adverse effects; D013988:Ticlopidine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives
D005464:Fluorobenzenes; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D010975:Platelet Aggregation Inhibitors; D011743:Pyrimidines; D013449:Sulfonamides; D000068718:Rosuvastatin Calcium; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin